0960B |
Cannabinoids Panel, Blood |
0960FL |
Cannabinoids Panel, Fluid |
0960SP |
Cannabinoids Panel, Serum/Plasma |
0960TI |
Cannabinoids Panel, Tissue |
0964U |
Cannabinoid Metabolite, Urine |
0966B |
Cannabis Plus Recent Use Markers, Blood |
0966SP |
Cannabis Plus Recent Use Markers, Serum/Plasma |
1858U |
Drugs of Abuse (9 Panel) and Alcohol Screen, Urine |
1861U |
Drugs of Abuse Screen (6 Panel), Urine |
1864U |
Drugs of Abuse Screen (10 Panel), Urine |
1874U |
Drug Screen (9 Panel), Urine |
1876U |
Drug Screen - Expanded, Urine |
8051U |
Postmortem, Basic, Urine (Forensic) |
8052U |
Postmortem, Expanded, Urine (Forensic) |
8061U |
Postmortem, Basic w/o Alcohol, Urine (Forensic) |
8062U |
Postmortem, Expanded w/o Alcohol, Urine (Forensic) |
8091U |
Drugs of Abuse (11 Panel) and Alcohol Screen, Urine |
8096U |
Drugs of Abuse Screen (11 Panel), Urine |
8101U |
Drugs of Abuse (11 Panel) and Alcohol Screen, Urine |
8104B |
Postmortem, Fire Death Screen, Blood (Forensic) |
8758U |
Hallucinogens Screen, Urine |
8892OF |
Delta-9 THC (Qualitative), Oral Fluid (Saliva) |
8897OF |
Drugs of Abuse (7 Panel) (Qualitative), Oral Fluid (Saliva) |
8898OF |
Drugs of Abuse (6 Panel) (Qualitative), Oral Fluid (Saliva) |
8900OF |
Delta-9 THC (Quantitative), Oral Fluid (Saliva) |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9356U |
Cannabinoids Screen, Urine |